Literature DB >> 29129390

Clinical significance of enlarged cardiophrenic lymph nodes in advanced ovarian cancer: Implications for survival.

Ismail Mert1, Amanika Kumar1, Shannon P Sheedy2, Amy L Weaver3, Michaela E McGree3, Bohyun Kim2, William A Cliby4.   

Abstract

OBJECTIVE: Advanced ovarian cancer (OC) commonly spreads to cardiophrenic lymph nodes (CPLNs), and is often visible on preoperative imaging. We investigated the prognostic significance of abnormal CPLNs in OC detected by preoperative CT scans using three different definitions.
METHODS: Patients undergoing primary debulking surgery for stage IIIC/IV with residual disease (RD) ≤1.0cm and a preoperative abdominopelvic CT scan available were included. Scans were reviewed by two blinded radiologists. We characterized abnormal CPLNs using three different definitions: i) qualitative assessment score (QAS); ii) nodes >7mm on the short axis; or, iii) nodes ≥10mm on the short axis. We compared overall survival (OS) using the log-rank test.
RESULTS: Of the 253 patients (mean age 64.0years), 136 had no gross residual disease (NGR) and 117 had RD. By the QAS definition, CPLNs were abnormal in 28 (11.1%) patients and removed in one case. Among patients with NGR, presence of abnormal CPLNs was associated with worse OS (median OS, 38.4 vs. 69.6months, p=0.08). We observed no association between abnormal CPLNs and OS among patients with RD (median OS, 37.5 vs. 28.5months, p=0.49). OS was significantly better in NGR group without abnormal CPLNs (median OS for NGR vs. RD, 69.6 vs. 28.5months, p<0.001); however, there was no difference in OS between patients with NGR versus RD when abnormal CPLNs were present (median OS, 38.4 vs. 37.5months, p=0.99). Lack of benefit from NGR when abnormal CPLNs were present was observed for all three definitions tested.
CONCLUSION: Abnormal CPLNs are an important predictor of survival in advanced stage OC. Management of abnormal CPLNs should be considered in treatment planning when the goal is NGR.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2017        PMID: 29129390     DOI: 10.1016/j.ygyno.2017.10.024

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  3 in total

Review 1.  Novel Surgical Strategies in the Treatment of Gynecological Malignancies.

Authors:  Martina Aida Angeles; Carlos Martínez-Gómez; Federico Migliorelli; Marie Voglimacci; Justine Figurelli; Stephanie Motton; Yann Tanguy Le Gac; Gwénaël Ferron; Alejandra Martinez
Journal:  Curr Treat Options Oncol       Date:  2018-11-09

2.  Acute pericarditis after transabdominal cardiophrenic lymph node dissection and pericardotomy during ovarian cancer debulking surgery: A case report.

Authors:  Dib Sassine; Dimitrios Nasioudis; Kathryn Miller; Rebecca Chang; Derman Basaran; Evan S Smith; Sarah Ehmann; Dennis S Chi
Journal:  Gynecol Oncol Rep       Date:  2020-12-11

3.  Postoperative chest liver herniation after cardiophrenic lymph node resection by a transdiaphragmatic approach following primary cytoreductive surgery for advanced endometrioid ovarian cancer: A case report.

Authors:  Hélène Leray; Laurent Brouchet; Yann Tanguy Le Gac; Sihem Bouharaoua; Philippe Otal; Gwenaël Ferron; Erwan Gabiache; Martina Aida Angeles; Carlos Martínez-Gómez; Alejandra Martinez
Journal:  Gynecol Oncol Rep       Date:  2021-02-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.